(19)
(11) EP 3 443 373 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.11.2023 Bulletin 2023/44

(45) Mention of the grant of the patent:
27.09.2023 Bulletin 2023/39

(21) Application number: 17713952.4

(22) Date of filing: 28.03.2017
(51) International Patent Classification (IPC): 
G01R 33/563(2006.01)
G01R 33/483(2006.01)
 G01R 33/56(2006.01)
(52) Cooperative Patent Classification (CPC):
G01R 33/4835; G01R 33/56; G01R 33/5608; G01R 33/56341
(86) International application number:
PCT/EP2017/057305
(87) International publication number:
WO 2017/178227 (19.10.2017 Gazette 2017/42)

(54)

METHOD FOR PRODUCING A WEIGHTED MAGNETIC RESONANCE IMAGE

VERFAHREN ZUR ERZEUGUNG EINES GEWICHTETEN MAGNETISCHEN RESONANZBILDES

MÉTHODE POUR PRODUIRE UNE IMAGE PAR RÉSONANCE MAGNÉTIQUE PONDÉRÉE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 11.04.2016 GB 201606108

(43) Date of publication of application:
20.02.2019 Bulletin 2019/08

(73) Proprietors:
  • The Institute of Cancer Research: Royal Cancer Hospital
    London, Greater London SW7 3RP (GB)
  • Royal Marsden Nhs Foundation Trust
    Sutton, Surrey SM2 5PT (GB)

(72) Inventors:
  • BLACKLEDGE, Matthew
    Sutton Greater London SM2 5NG (GB)
  • COLLINS, David
    Sutton Surrey SM2 5PT (GB)
  • LEACH, Martin
    Sutton Surrey SM2 5PT (GB)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)


(56) References cited: : 
US-A- 6 163 152
 US-A1- 2012 068 703
   
  • BLACKLEDGE MATTHEW DAVID ET AL: "Noise-corrected exponential DWI using multi-acquisition MRI facilitates quantitative evaluation of whole-body skeletal tumour burden in patients with metastatic prostate cancer", PROCEEDINGS OF THE INTERNATIONAL SOCIETY FOR MAGNETIC RESONANCE IN MEDICINE, 24ND ANNUAL MEETING AND EXHIBITION, SINGAPORE, 7-13 MAY 2016, vol. 24, 23 April 2016 (2016-04-23), page 2422, XP040683463,
  • SERGIOS GATIDIS ET AL: "Apparent diffusion coefficient-dependent voxelwise computed diffusion-weighted imaging: An approach for improving SNR and reducing T 2 shine-through effects", JOURNAL OF MAGNETIC RESONANCE IMAGING, vol. 43, no. 4, 8 September 2015 (2015-09-08), pages 824-832, XP055377947, US ISSN: 1053-1807, DOI: 10.1002/jmri.25044 cited in the application
  • MATTHEW D BLACKLEDGE ET AL: "Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study", PLOS ONE, vol. 9, no. 4, 7 April 2014 (2014-04-07), page e91779, XP055377906, US ISSN: 1932-6203, DOI: 10.1371/journal.pone.0091779 cited in the application
  • MATTHEW D BLACKLEDGE ET AL: "Computed Diffusion-weighted MR Imaging May Improve Tumor Detection", RADIOLOGY, vol. 261, no. 2, 1 November 2011 (2011-11-01), pages 573-581, XP055377890, DOI: 10.1148/radiol.11101919/-/DC1 cited in the application
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).